Here at Capsida we welcomed the start of summer with a company-wide BBQ! Our team enjoyed some delicious eats and sunshine to start the season off right. #Capsida #Summer #BBQ
Capsida Biotherapeutics
Biotechnology
Newbury Park, CA 12,650 followers
Engineering novel AAVs and developing the next generation of gene therapies
About us
Capsida Biotherapeutics Inc. is an industry-leading gene therapy platform company creating a new class of targeted, non-invasive gene therapies for patients with debilitating and life-threatening genetic disorders. Capsida's technology allows for the targeted penetration of cells and organs, while limiting collateral impact on non-targeted cells and organs, especially the liver. This technology allows for the delivery of the gene therapy in a non-invasive way through intravenous administration. Capsida's technology is protected by a growing intellectual property portfolio which includes more than 30 patent applications and one issued U.S. patent 11,149,256. The company is exploring using the technology across a broad range of life-threatening genetic disorders. Its initial pipeline consists of multiple neurologic disease programs. The company has strategic collaborations with AbbVie and CRISPR, which provide independent validation of Capsida's technology and capabilities. Capsida is a multi-functional and fully integrated biotechnology company with proprietary adeno-associated virus (AAV) engineering, multi-modality cargo development and optimization, translational biology, process development and state-of-the-art manufacturing, and broad clinical development experience. Capsida's biologically driven, high-throughput AAV engineering and cargo optimization platform originated from groundbreaking research in the laboratory of Viviana Gradinaru, Ph.D., a neuroscience professor at the California Institute of Technology.
- Website
-
http://www.capsida.com
External link for Capsida Biotherapeutics
- Industry
- Biotechnology
- Company size
- 51-200 employees
- Headquarters
- Newbury Park, CA
- Type
- Privately Held
- Founded
- 2019
- Specialties
- Biotechnology, AAV Engineering, Gene Therapy, Biopharmaceuticals, Protein Engineering, Analytical Development, Process Development, and AAV Immunology
Locations
-
Primary
Get directions
1290 Rancho Conejo Blvd
Newbury Park, CA 91320, US
Employees at Capsida Biotherapeutics
Updates
-
Capsida’s David Goertsen, Ph.D., will be presenting at the 4th Next Generation Gene Therapy Vectors Summit, focused on Innovating Gene Therapy Capsid & Payload Design. Dr. Goertsen’s presentation will review Capsida’s progress in AAV capsid engineering to develop gene therapy candidates with improved safety and efficacy profiles for PD-GBA and genetic epilepsy due to STXBP1: • Platform advancements leading to breakthrough, IV-delivered engineered AAV capsids for the CNS • Generations of directed evolution yielding highly targeted AAV capsids with increased therapeutic index • Potential for Capsida's engineered AAVs to treat neurological disorders across all age groups This summit brings together more than 60 biopharma leaders, service providers, and academic pioneers to discuss the latest advancements and innovations in vector development for gene therapies. 📅 Event: 4th Next Generation Gene Therapy Vectors Summit 📍 Location: Boston 🗓️ Date: June 14 at 2:15pm #GeneTherapy #AAV #Biopharma #Capsida #Innovation #NextGenVectorsSummit #NeurologicalDisorders #R&D
-
-
Great to be at BIO 2024! #BIO2024 #Genetherapy #CapsidaBiotherepeutics
-
-
🇺🇸 Honoring Memorial Day at Capsida 🇺🇸 Today, we pause to honor and remember the brave people who have made the ultimate sacrifice in service to our country. Memorial Day is a time of reflection, gratitude, and remembrance, and at Capsida, we join the nation in paying tribute to these heroes. #MemorialDay #HonorAndRemember #CapsidaCares #Gratitude https://lnkd.in/duW8-Xq
-
-
From fragrant curry from India to comforting pasta from Italy, spicy jerk chicken from Jamaica, and savory tagine from Morocco, our recent Cultural Diversity Day potluck showcased the flavors, traditions, and stories that make each of us unique. Team members brought their favorite dishes, each one speaking to their cultural heritage or holding a special place in their hearts. To add an extra layer of connection, many included the recipes for their dishes along with brief explanations of their significance. We shared not just food but the stories and traditions behind them. We came together to appreciate the beauty of our differences and the deliciousness that unites us. #CulturalDiversityDay #DiversityAndInclusion #FoodBringsUsTogether
-
-
We are pleased to share an article in BioSpace that features Capsida’s advancements in developing targeted, systemically delivered gene therapies with improved safety and efficacy. Take a look: https://lnkd.in/gF4swNh9
-
We would like to say a big THANK YOU to everyone who helped make ASGCT a success last week! We were honored to participate and present our data and next generation gene therapies as we advance towards the clinic. If you missed any of our presentations, you can access them here: capsida.com/publications Thank you all and we look forward to next year! #ASGCT2024 #GeneTherapy #CapsidaBiotherapeutics #BaylorCollegeOfMedicine
-
We are pleased to be hosting a panel by HBA Pacific Region HBA Los Angeles entitled, “Empowering Women in Healthcare Leadership” featuring Capsida’s Bethany Mancilla. We look forward to a lively discussion and networking opportunity with leaders in healthcare in the LA region. https://lnkd.in/g8sva-kc
HBA Los Angeles presents: “Empowering Women in Healthcare Leadership,” a panel discussion hosted by Capsida Biotherapeutics and co-sponsored by IPM Integrated Project Management Company. 🌟This is a great opportunity to network and participate in roundtable discussions with some fantastic women in LA Biotech. 🗓 Wednesday, May 15, 2024 from 5-8pm 📍 Capsida Biotherapeutics, 1300 Rancho Conejo Blvd, Thousand Oaks Distinguished panelists: Holly Carlisle, VP Translational Science, Latigo Biotherapeutics, Inc. David Lucas, VP Workforce Strategy & Optimization, Amgen Bethany Mancilla, Chief Business Officer, Capsida Biotherapeutics Moderator: Veronica Lindop, Principal Consultant, IPM Integrated Project Management Company 🚀Join us to participate in dynamic breakout discussions and a moderated panel, advice on navigating career paths, overcoming challenges, and driving meaningful impact in healthcare leadership. 📣 Register at https://lnkd.in/ginj_j4Y Agenda: 5:00PM-5:30PM: Registration and networking 5:30PM-5:45PM: Welcoming remarks 5:45PM-6:30PM: Break out sessions 6:30PM-7:30PM: Panel discussion 7:30PM-8:00PM: Networking Poornima Shubhakar Helen McBride Shannon Lee Topinka, MBA, PMP Elizabeth Watt, PhD Segolene Reille Kamala Lakamsani Jessica Galvin, MPA Marielle A. Hajducko, MBA Tracy Nanfito
-
-
A big congratulations to Capsida’s director of preclinical research Kimberly McDowell Ph.D., who was awarded the Healthcare Businesswomen’s Association’s 2024 Rising Star Award at a gala ceremony in New York City this weekend. Well done, Kim and all the other award recipients! Original post about Kim: https://lnkd.in/gywgscgm
-
-
We are excited to present groundbreaking preclinical data on our gene therapy candidate CAP-003 at the American Society of Gene & Cell Therapy Annual Meeting. Our PD-GBA program is in IND enabling studies and is expected to enter the clinic in 1H 2025. PD-GBA is estimated to affect up to 15% of the more than 10 million adults worldwide with PD. See our full press release here: https://bit.ly/4b8J8iT Title: Systemic AAV Gene Therapy with CNS-Targeted Engineered Capsids Achieves Significant GCase Activity Increases in the Primate Brain to Support the Potential Treatment of GBA-PD 🗓️ Date: Friday, May 10, 2024 🕒 Time: 3:00-3:15 PM ET 📍 Session: Neurologic Diseases III 🔍 Abstract Number: 274 🏢 Location: Room 307-308 Presenter: Nicholas Flytzanis, Ph.D., Founder and Chief Research and Innovation Officer, Capsida We look forward to seeing you there! #ASGCT2024 #GeneTherapy #NeurologicalDiseases #GBA-PD #ParkinsonsDiseaseMonth
-